Background: Persistent postoperative pain (PPP) is common after total knee arthroplasty (TKA). The primary aim of this prospective cohort study was to identify important predictors of moderate to severe PPP 6 and 12 months after TKA. Methods: Consenting patients (n¼300) undergoing primary unilateral TKA attended a preoperative session to collect clinical information (age, gender, BMI, preoperative knee pain, comorbid pain, likely neuropathic pain) and psychological variables (depression, anxiety, catastrophising, expected pain). Quantitative sensory testing (pressure pain thresholds, temporal summation, conditioned pain modulation) was performed, and blood samples were obtained for subsequent genotyping of OPRM1 and COMT. Acute postoperative pain was measured at rest and during movement. Surgical factors (surgery time, patella resurfacing, anaesthetic type) were collected after operation. Follow-up questionnaires were sent 6 and 12 months after surgery. Multivariate logistic regression was used to identify predictors of PPP. Results: The prevalence of moderate to severe PPP was 21% (n¼60) and 16% (n¼45) 6 and 12 months after surgery, with 55% (n¼33) and 60% (n¼31) of PPP likely neuropathic in nature. At 6 months, a combination of preoperative pain intensity, expected pain, trait anxiety, and temporal summation (Akaike information criterion, 309.9; area under receiver operating characteristic (ROC) curve, 0.70) was able to correctly classify 66% of patients into moderate to severe PPP and no to mild PPP groups. At 12 months, preoperative pain intensity, expected pain, and trait anxiety (Akaike information criterion, 286.8; area under ROC curve, 0.66) correctly classified 66% of patients.
Managing persistent pain after total knee arthroplasty needs improved understanding of modifiable risk factors. Clinical, psychological, psychophysical, and genetic factors were assessed up to 12 months after surgery. Persistent pain and disability was present in 16% of patients at 12 months. Predictive factors for persistent pain (12 months) were preoperative pain intensity, trait anxiety, and expected pain. Future work is required to assess the impact of interventions to modify these factors.
Total knee arthroplasty (TKA) is an effective intervention to improve physical function and reduce joint pain in those with end-stage knee arthritis. 1 Although TKA relieves pain in most patients, between 10% and 34% continue to experience moderate to severe persistent postoperative pain (PPP) in the operated knee !3 months after surgery. 2 PPP adversely affects quality of life, 3 is the most important predictor of patient dissatisfaction after TKA, 4 and is a common reason for undergoing revision surgery. 5 The aetiology of PPP after TKA is multifactorial and likely involves both patient-and treatment-related factors. 6 Although a number of studies have examined preoperative risk factors for the development of PPP after TKA, 7 many of these have been retrospective in nature or focused on a limited number of variables. Including a range of potential clinical, psychological, neurophysiological, genetic, and surgical risk factors for PPP may better control for confounding variables and allow the relative importance of these factors to be evaluated. 6, 8 The primary aim of this prospective cohort study was to identify key predictors of moderate to severe PPP 6 and 12 months after primary unilateral TKA. The secondary aims were to evaluate the proportion of patients with moderate to severe PPP whose pain was likely neuropathic in nature and to explore the link between PPP and functional outcome.
Methods

Patients and study design
This prospective cohort study was approved by the New Zealand Northern Regional Y Ethics Committee (NTY12/02/014) and registered (ACTRN12612001089820). All patients provided written, informed consent. Inclusion criteria were planned primary unilateral TKA and fluent in English. Exclusion criteria were <18 yr old, diagnosed learning disability, Raynaud's syndrome, unsuitable for neuraxial anaesthesia, and a diagnosed neurological condition that may affect quantitative sensory testing (QST) or revision surgery within the follow-up period. Patients were recruited between November 2012 and September 2015 from the Waitemata District Health Board, an Auckland-based hospital board with three operating sites. Consenting patients attended a preoperative assessment session in the 2 weeks before surgery. Clinical information was collected, questionnaires completed, QST procedures undertaken and a 6 ml blood sample collected for subsequent genetic analysis. Acute postoperative pain (APOP) was measured on Days 1, 2, 3, 7, and 14 after surgery. Follow-up questionnaires were sent to patients 6 and 12 months after surgery.
Intervention
All patients underwent a unilateral, cemented TKA. Patella resurfacing was performed according to clinical indication. A standard enhanced recovery after surgery (ERAS) protocol was recommended for all study patients, including combined spinal epidural (CSE) with sedation. During the study period there was the introduction of high volume local infiltration analgesia (LIA) through a modified ERAS programme. As such, the initial CSE protocol transitioned into single shot spinal with LIA. All other aspects of the anaesthesia/analgesia protocol remained the same. For patients undergoing CSE, patientcontrolled epidural analgesia (PCEA) was utilised for 48 h after surgery, with no background infusion. All patients, including those who received single shot spinal plus LIA, had multimodal postoperative analgesia including regular oral acetaminophen (paracetamol), NSAIDs, and oral opioids (oxycodone) as required. Gabapentin was available as 'rescue' medication only.
Predictor variables
The predictor variables included are listed in Table 1 and were based on existing literature.
Clinical factors
Age, gender, and preoperative BMI were collected before operation. The Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) pain scale was completed to obtain a measure of preoperative knee pain intensity. 9 A preoperative comorbid pain score was calculated by counting the number of additional pain sites where pain was present for 1 month or longer and rated !3/10. 10, 11 The Leeds Assessment of Neuropathic Signs and Symptoms Pain Questionnaire (LANSS) was completed before operation. The LANSS was utilised both to identify participants with likely neuropathic pain before surgery (cut point of !12), and as a predictor (continuous score) of PPP.
12
APOP in the operated knee was measured at rest and during movement. 13 Resting APOP was recorded in supine with the participant's knee in a resting position for !30 s. Movement APOP was recorded during a standardised movement from full knee extension to maximum active knee flexion. Rest and movement APOP were measured on Days 1, 2, and 3 (in hospital) and Days 7 and 14 (over the phone) after surgery using a scale from 0 to 100 (where 0¼no pain; 100¼extreme pain).
Psychological factors
The Pain Catastrophising Scale, 14 Beck Depression Inventory II, 15 and State Trait Anxiety Inventory 16 were completed before operation. Expected pain was also measured using a single question, 'Please indicate the level of pain you think you will experience in your operated knee 6 months after your surgery?', scored on a 0e10 numerical rating scale (0¼no pain; 10¼extreme pain).
Quantitative sensory testing
Temporal summation was calculated as the difference in pain intensity (0¼no pain; 100¼worst pain imaginable) between the 10th stimulus of a 1 Hz train of stimuli and a single stimulus to a 1 cm 2 area of the skin over the medial joint line using a #6.45
(180 g) monofilament. Pressure pain threshold (PPT) was measured over the contralateral shoulder (midway between the C7 spinous process and acromion) and the affected knee (medial joint line). A handheld pressure algometer (Sbmedic Electronics, Solna, Sweden) with a 1 cm 2 probe and ramping rate of 30 kPa s À1 was used. Patients were instructed to push a button when the sensation 'first becomes painful'. PPT was obtained as the average of three measures at each site, with a 30 s rest given between measures. To assess conditioned pain modulation (CPM), the contralateral hand was immersed in cold water with a mean (standard deviation) temperature of 8(2) C until cold pain of !3/10 was reported. At this time, PPT was repeated at the knee. CPM was the percentage change in knee PPT during cold water immersion (conditioned stimulus) compared with knee PPT alone (test stimulus) and multiplied by e1 so that negative values indicated inhibition. 17 
Genetic factors
DNA was extracted from ethylenediaminetetraacetic acid (EDTA)-treated whole blood. 18 Patients were genotyped for the OPRM1 (rs1799971) polymorphism (SNP) as described previously, 18 and for the COMT (rs4680) SNP by commercially available TaqMan ® SNP genotyping assay using the following optimised conditions: 1Â iTaq Universal Probes Supermix (Bio-Rad, Gladesville, NSW, Australia), 0.75Â Genotyping Assay Mix (C_25746809_50; ThermoFisher Scientific Inc., Waltham, MA, USA), 20 ng of DNA and nuclease-free water (ThermoFisher Scientific Inc.) in 20 ml reaction volume; thermal cycling at 95 C for 3 min then 39 cycles of 95 C for 5 s and 67 C for 30 s followed by fluorescence measurement [CFX96 real-time PCR system (Bio-Rad); allelic discrimination using CFX Manager 3.0 software (Bio-Rad)]. Genotype controls (described previously) 19 and two non-template controls were included in every assay run.
Surgical factors
Perioperative factors including the total surgical time (in minutes), patella resurfacing (yes/no), and anaesthetic type (CSE; spinal plus LIA or other) were collected from medical records.
Outcome variables
Primary outcome
The primary outcome was the presence of moderate to severe PPP (WOMAC pain, !30/100) in the operated knee 6 and 12 months after operation. 9 A score of !30/100 defines moderate to severe pain, 20 and people with arthritis 21 and after TKA 22 typically find this pain intensity unacceptable.
Secondary outcomes
The WOMAC function scale (0e100) assessed disability 6 and 12 months after TKA. The Self-Complete Leeds Assessment of Neuropathic Signs and Symptoms (S-LANSS) questionnaire assessed likely neuropathic knee pain at 6 and 12 months, using a cut point of !12. or Fisher's exact tests were used for categorical variables. Spearman's correlation was used to examine the relationship between WOMAC pain and WOMAC function. ManneWhitney U-tests were completed to examine differences in WOMAC function between patients with and without moderate to severe PPP and to explore differences in WOMAC pain and function between patients with and without 'likely neuropathic' pain. Multivariate logistic regression models were then developed to examine predictors of moderate to severe PPP 6 and 12 months after surgery. Models were developed using a stepwise approach, accounting for interaction and collinearity. Model covariates were included if variance inflation factors were ˂2 and their correlations with one another were ˂0.4. Sensitivity and specificity were calculated, along with receiver operating characteristic (ROC) analyses. Final models were chosen by a combination of superior area under the curve (AUC), Akaike information criterion (AIC), and Youden index. Goodness-of-fit was appraised using the Hosmer and Lemeshow methodology. A significance level of 5% (P<0.05), and confidence intervals of 95% were used. Statistical analyses were carried out using SPSS v. 24 (IBM Corp., Armonk, USA) and Stata v. 14 (Statacorp., Texas, USA).
Results
Of 1198 patients who were screened for inclusion, 363 met the inclusion/exclusion criteria and provided consent, but 63 patients were excluded before undergoing surgery (Fig. 1) . The remaining 300 patients underwent baseline testing, had surgery, and were eligible for follow-up (Table 2) , which was obtained from 291 patients (97%) at 6 months and 288 (96%) at 12 months. No genotype frequencies deviated from Hardye Weinberg equilibrium (P>0.26). Because of a high number of missing values from the in-hospital APOP data, rest and movement pain intensity from Day 7 (n¼ 293) and Day 14 (n¼297) were used as the measures of APOP in all analyses. Full data sets were available for all other variables.
Persistent postoperative pain
WOMAC pain decreased from a mean (standard deviation) of 47 (20) /100 before surgery to 16 (18)/100 at 6 months and 12 (15)/100 at 12 months. Despite this, the prevalence of moderate to severe PPP (WOMAC pain, !30/100) was 21% (n¼60) and 16% (n¼45) at 6 and 12 months, respectively. There was a significant association between WOMAC pain and WOMAC function 
Likely neuropathic pain
Before surgery, 6% (n¼18) of patients had likely neuropathic pain. This increased to 26% (n¼77) and 25% (n¼71) 6 and 12 months after surgery. Amongst patients with moderate to severe PPP, 55% (n¼33) and 60% (n¼31) had likely neuropathic pain at 6 and 12 months. Across all patients, those with likely neuropathic pain reported higher pain intensity (both P<0.001) and more disability (both P<0.001) at 6 and 12 months.
Predictors of persistent pain
Descriptive statistics and results of the between group analysis are presented in Table 3 . For multivariate analysis, 191 logit models were evaluated at 6 months and 203 models at 12 months. The models with the best combination of high AUC, low AIC, and high Youden index were chosen and are presented in Table 4 (6 months) and Table 5 (12 months). At 6 and 12 months, the likelihood ratio test was significant (both P<0.001) whereas the Hosmer and Lemeshow goodness-of-fit test was not (both P>0.584), indicating no concerns with the overall model fit. At 6 months, the predictor variables remaining in the final model were preoperative pain intensity, temporal summation, trait anxiety, and expected pain. The AUC was 0.70, with 66% of patients correctly classified. At 12 months, preoperative pain intensity, trait anxiety, and expected pain remained in the final model. The AUC was 0.66 with 66% of patients correctly classified.
Discussion
This prospective cohort study is the most comprehensive examination of risk factors for PPP in a TKA population to date. Although TKA effectively reduced pain in most patients, 16e21% reported moderate to severe PPP in the operated knee 6e12 months after surgery, in agreement with previous studies. 2 The most important predictive factors in our final multivariate models were preoperative knee pain intensity, trait anxiety, expected pain, and temporal summation. Higher intensity preoperative pain has been consistently linked to worse long-term pain outcomes, having previously been associated with greater PPP 6 months to 5 yr after TKA. 7 Accordingly, preoperative pain intensity remained in the final multivariate models at both 6 and 12 months. Increased arthritis pain is associated with enhanced temporal summation, 24 an indicator of preoperative central sensitisation.
Although temporal summation was not a predictor of PPP outcome at 12 months in our cohort, it did remain in the final multivariate model at 6 months. This supports findings from studies showing that higher levels of preoperative temporal summation are associated with greater PPP 25 and less pain relief after TKA. 26 The influential effects of preoperative pain in our study and, to a lesser extent, temporal summation, highlight the importance of an optimal pain management strategy, including timing of surgical intervention. The best time to operate on patients with arthritis is poorly understood. For some patients, effective conservative management (e.g. optimising analgesics, weight control, and exercise) may successfully delay surgery. However, as pain intensity typically worsens with arthritis progression, 27 prolonged delay of arthroplasty may also be a risk factor for PPP. Thus, some patients may benefit from earlier surgical intervention or the use of centrally acting analgesics (e.g. serotonine noradrenaline reuptake inhibitors; N-methyl-D-aspartate receptor blockers). Expected pain remained in the final multivariate models at both 6 and 12 months. Its importance has previously been found to predict pain relief from TKA. 28e30 The antecedents of pain expectations after TKA are poorly understood but may be related to self-efficacy 31 and dispositional differences in pessimism/optimism. 32 Patients who are pessimistic are more than twice as likely to develop moderate to severe PPP after TKA. 33 Trait anxiety also remained in the multivariate models at both 6 and 12 months. The potential importance of anxiety is supported by previous observations, with trait anxiety being an independent predictor of PPP 6 months 34 and 1 yr 35 after TKA.
Although trait characteristics are by definition more persistent, they are not unmodifiable. 36 For example, several studies in different populations have shown that trait anxiety can be modified with appropriate cognitive behavioural therapy. Thus, cognitive behavioural interventions in the perioperative period aimed at reducing the threat value of surgery and of postoperative pain, improving patients' coping strategies, 40 and enhancing self-efficacy 31 might help to reduce the risk of PPP after TKA. Furthermore, there is some evidence that anxiolytic medications can diminish perioperative anxiety and reduce APOP, 41, 42 although its effects on PPP are unclear.
Despite measuring a large number of previously identified risk factors, the overall predictive value of our final models was only fair, with approximately two out of three patients able to be correctly classified (Tables 4 and 5 ). This is slightly lower than those reported in other large prospective cohort studies performed in different surgical populations. 10, 43 These findings suggest that other (unmeasured) factors may have played an important role in determining who developed moderate to severe PPP in our cohort. Although the heritability of PPP has not yet been established, twin studies suggest that the heritability of other chronic pain conditions is between 30% and 70% (median,~45%). 44 Thus, although we were unable to show an association between PPP and the specific SNPs included in this study, it seems likely that other, as-yetunidentified gene variants (e.g. ion channel or cytokine polymorphisms) play an important role in those who develop PPP after TKA, and should be explored in future research. 44, 45 Furthermore, this study analysed only single SNPs, rather than a haplotype analysis based on polymorphisms at several related gene loci. 46 Such an approach may have improved our ability to observe a relationship between genotype and PPP. Our primary focus was on measuring preoperative risk factors for the development of PPP. However, such an approach may be inherently limited if patients are exposed to other important risk factors for PPP in the perioperative period (e.g. intraoperative nerve damage; opioid-induced hyperalgesia) that alter their long-term pain outcome. In this regard, an important finding from our study was that the proportion of patients with likely neuropathic pain increased from 6% before surgery to~25% at the 6 and 12 month follow-ups, with 55e60% of those suffering from moderate to severe PPP also meeting the cut-off for likely neuropathic pain. These findings suggest that a notable portion of PPP after TKA arises from, or is worsened by, the surgery itselfdlikely as a result of intraoperative nerve injury, neuroinflammation, or both. 47, 48 Nerve 59 (26) 7 (12) 60 (25) 3 (7) 1, n (%)
50 (22) 12 (20) 52 (21) 9 (20) 2, n (%)
47 (20) 12 (20) 52 (21) 7 (16) 3, n (%)
34 (15) 18 (30) 37 (15) 14 (31) 4, n (%)
14 (6) 5 (8) 15 (6) 5 (11) 5, n (%)
15 (6) 3 (5) 13 (5) 5 (11) !6, n (%)
12 (5) 3 (5) 14 (6) 50 (22) 13 (22) 49 (20) 11 (25) G/G allele, n (%) 1 (0) 0 (0) 1 (0) 1 (2) damage is likely with any surgical procedure, and it should be emphasised that not all nerve injuries will cause PPP. 48 Nonetheless, more extensive nerve damage increases the risk of developing moderate to severe neuropathic pain. 49 Thus, strategies to minimise nerve injury and inflammation, such as an alternative surgical approach, glucocorticoids, minimally invasive surgery, or reduced tourniquet time should be examined in future studies to see if these reduce the incidence of PPP after TKA.
This study has several strengths, including its large sample size, comprehensive range of risk factors examined, and minimal loss to follow-up at 6 and 12 months. However, some additional limitations should be considered. First, the singlecentre design of our study limits the generalisability of our findings. Second, the large number of missing values in the inhospital APOP data (Days 1, 2, and 3) meant that we were unable to include this as a predictor variable in our final models. However, previous studies suggest the trajectory of APOP may be particularly important to the development of PPP, with patients who demonstrate high intensity pain that persists many days after surgery at greatest risk. 50 In conclusion the results of this study provide some basis for the identification of patients at risk of PPP after TKA and highlight several modifiable factors that may be targeted by clinicians in an attempt to reduce the risk of developing PPP. Strategies to minimise intraoperative nerve injury, reduce preoperative pain intensity, and address preoperative psychological factors such as expected pain and anxiety may lead to improved outcomes after TKA and should be explored in future intervention studies. 
